drugset / Trial / NCT03237156
Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male Participants
RandomizedParallel-groupDouble-blindOther
Summary
The purpose of this study is to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of TAK-906 in Japanese healthy male participants.
Timeline
- Start
- 2017-08-07
- Primary completion
- 2017-10-07
- Completion
- 2017-10-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Trazpiroben | Small molecule | 10 mg | Oral |
| Subject | Trazpiroben | Small molecule | 50 mg | Oral |
| Subject | Trazpiroben | Small molecule | 100 mg | Oral |
Indications
No indication recorded.